NCT00034658View on ClinicalTrials.gov

Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041)

PHASE3CompletedINTERVENTIONAL
Enrollment

336

Participants

Timeline

Start Date

December 31, 1998

Primary Completion Date

March 31, 2002

Study Completion Date

March 31, 2002

Conditions
Mycoses
Interventions
DRUG

Posaconazole

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00034658 - Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041) | Biotech Hunter | Biotech Hunter